Annual report pursuant to Section 13 and 15(d)

NOTE 11 - OPTIONS AND WARRANTS (Details) - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

v2.4.1.9
NOTE 11 - OPTIONS AND WARRANTS (Details) - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2014
NOTE 11 - OPTIONS AND WARRANTS (Details) - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]    
Estimated fair value of the Company’s common stock (in Dollars per share)   $ 2.09us-gaap_SharePrice
Series C Preferred Stock [Member] | Warrant [Member]    
NOTE 11 - OPTIONS AND WARRANTS (Details) - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]    
Dividend yield: 0.00%us-gaap_FairValueAssumptionsExpectedDividendRate
/ bios_EquityTransactionAxis
= us-gaap_WarrantMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember
 
Volatility 125.33%us-gaap_FairValueAssumptionsExpectedVolatilityRate
/ bios_EquityTransactionAxis
= us-gaap_WarrantMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember
 
Risk free rate: 1.40%us-gaap_FairValueAssumptionsRiskFreeInterestRate
/ bios_EquityTransactionAxis
= us-gaap_WarrantMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember
 
Expected life: 5 years  
Estimated fair value of the Company’s common stock (in Dollars per share) $ 2.09us-gaap_SharePrice
/ bios_EquityTransactionAxis
= us-gaap_WarrantMember
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember